As Northrop Grumman (NOC) Drops, Investors Seek Opportunity

This afternoon we watched Northrop Grumman drop -5.4% to a price of $461.43 per share. The large-cap Aerospace & Defense company is now trading -17.74% below its average target price of $560.95. Analysts have set target prices ranging from $375 to $700 per share for Northrop Grumman, and have given the stock an average rating of buy.

Northrop Grumman's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.2%. The stock's short ratio is 2.53. The company's insiders own 0.22% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 85.1%. In conclusion, we believe there is mixed market sentiment regarding Northrop Grumman.

Institutions Invested in Northrop Grumman

Holder Shares Date Reported Percentage Value
State Street Corporation 14,366,015 2022-09-29 9% $6,628,910,196
Capital International Investors 12,233,419 2022-09-29 8% $5,644,866,439
Vanguard Group, Inc. (The) 12,131,490 2022-09-29 8% $5,597,833,341
Blackrock Inc. 9,131,144 2022-09-29 6% $4,213,383,709
Wellington Management Group, LLP 6,818,168 2022-09-29 4% $3,146,107,210
FMR, LLC 6,576,817 2022-09-29 4% $3,034,740,620
Massachusetts Financial Services Co. 5,254,838 2022-09-29 3% $2,424,739,859
JP Morgan Chase & Company 3,582,672 2022-09-29 2% $1,653,152,314
Morgan Stanley 3,238,285 2022-09-29 2% $1,494,241,823
Sanders Capital, LLC 3,057,766 2022-09-29 2% $1,410,944,942
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.